Loading…
Methods for treating erectile dysfunction with a cGMP-specific phosphodiesterase 5 inhibitor pharmaceutical composition
Year of Publication 31.05.2022
Get full text
Patent
Loading…
METHODS FOR TREATING ERECTILE DYSFUNCTION WITH A CGMP-SPECIFIC PHOSPHODIESTERASE 5 INHIBITOR PHARMACEUTICAL COMPOSITION
Year of Publication 24.05.2022
Get full text
Patent
Loading…
METHODS FOR TREATING ERECTILE DYSFUNCTION WITH A CGMP-SPECIFIC PHOSPHODIESTERASE 5 INHIBITOR PHARMACEUTICAL COMPOSITION
Year of Publication 13.06.2019
Get full text
Patent
Loading…
METHODS FOR TREATING ERECTILE DYSFUNCTION WITH A CGMP-SPECIFIC PHOSPHODIESTERASE 5 INHIBITOR PHARMACEUTICAL COMPOSITION
Year of Publication 13.06.2019
Get full text
Patent
Loading…
A phase I, randomized, proof‐of‐clinical‐mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral PDE9A inhibitor BI 409306 in healthy male volunteers
Boland, Katja, Moschetti, Viktoria, Dansirikul, Chantaratsamon, Pichereau, Solen, Gheyle, Lien, Runge, Frank, Zimdahl‐Gelling, Heike, Sand, Michael
Published in Human psychopharmacology (01.01.2017)
Published in Human psychopharmacology (01.01.2017)
Get full text
Journal Article
Loading…